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Abstract
We report the complete amino acid sequence of callinectin, a 32 amino acid, proline-, arginine-
rich AMP with four cysteines and having the sequence
WNSNRRFRVGRPPVVGRPGCVCFRAPCPCSNY-amide. The primary structure of callinectin
is highly similar to arasins, AMPs recently identified in the small spider crab (Hyas araneus).
Callinectin exists in three isomers that vary in the functional group on the tryptophan (W) residue.
The most prevalent isomer had a hydroxy-N-formylkynurenine group, while the other two isomers
had either N-formylkynurenine or hydroxy-tryptophan. Using a sequence highly similar to native
callinectin, we chemically synthesized a peptide which we called callinectin-like peptide (CLP).
Via immunoelectron microscopy, affinity-purified rabbit antibodies raised to CLP successfully
localized the site of callinectin in blue crab hemocytes to the large electron-dense granules that are
found primarily in large granule hemocytes.
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The blue crab (Callinectes sapidus) is a keystone species in many estuaries of the western
Atlantic Ocean and the Gulf of Mexico (Anonymous, 1999; Hines, 2007). It is a member of
the family Portunidae (swimming crabs), which also includes other ecologically and
commercially important species, such as the mud crabs (Scylla spp.), of the Indo-Pacific
region. Wild blue crabs have frequently been affected by infectious disease epidemics,
especially bacteria and parasites (Noga et al., 1998; Lee and Frischer, 2004; Shields and
Overstreet, 2007). Cultured blue crabs, such as those held in shedding operations for the
production of “soft-shelled” crabs, have also been plagued by disease (Noga et al., 1998).
While disease causes serious losses, we know little about the mechanisms blue crabs use to
protect themselves from infection. Antimicrobial peptides (AMPs) are typically potent,
broad-spectrum chemical defenses. In recent years, a number of AMPs have been identified
in various crab species, including a proline-rich 6.5 kDa peptide from the shore crab
(Carcinus maenas) (Schnapp et al., 1996), crustins from green crab (Carcinus maenas) (Relf
et al., 1999) and mud crab (Scylla paramamosain) (Imjongjirak et al., 2009),
antilipopolysaccharide factors from mud crab (Imjongjirak et al., 2007), mangrove mud crab
(S. serrata ) (Yedery and Reddy, 2009), Chinese mitten crab (Eriocheir sinensis) (Li et al.,
2008) and swimming crab (Portunus trituberculatus) (Yue et al., 2010), as well as arasin
(proline-arginine-rich peptide) and hyastatin (glycine-rich multidomain peptide) from the
small spider crab (Hyas araneus) (Stensvåg et al., 2008, Sperstad et al., 2009).
Blue crabs also synthesize an AMP, callinectin, in the hemocyte fraction of hemolymph
(Khoo et al., 1999), which was one of the first AMPs identified from any crab. However,
only a partial sequence (about 2/3 of this peptide) was determined. The purpose of our
present study was to elucidate the entire primary structure of callinectin. In addition, we
wished to use these data to develop an antibody probe that would identify the cellular
location of callinectin in blue crab immunocytes.
2. MATERIALS AND METHODS
2.1 Sequence Determination of Callinectin
Native callinectin was purified as described previously (Khoo et al., 1999). The intact mass
of callinectin was initially performed using Matrix Assisted Laser Desorption Mass
spectrometry (MALDI-MS) on a Micromass TofSpec-SE in linear mode. Four μl (~ 4
pmoles) of HPLC-purified, non-alkylated callinectin (see below) was diluted into 6 μl of
70% formic acid. One μl was removed and mixed with one μl of alpha-cyano-4-hydroxy
cinnamic acid matrix in 0.1% trifluoroacetic acid (TFA), 50% acetonitrile, 50% water, with
one μl of internal calibrants. The internal calibrants used (to maintain better than 100 ppm
mass accuracy) were 25 fmol bradykinin (protonated monoisotopic mass of 1060.57 Da) and
ACTH clip (protonated monoisotopic mass of 2465.2 Da). The average protonated mass of
callinectin was determined to be 3647 Da with 3 masses at +16 Da from this parent mass
(indicating sites of oxidation) with the most intense mass at 3695.2 Da.
Approximately 400 pmoles (two μl) of purified callinectin, dissolved in 10 μl of 8 M urea/
0.4 M ammonium bicarbonate, was reduced by adding five μl of 45 mM dithiothreitol and
incubating at 37°C for 20 min. The sample was then alkylated by adding five μl of 100 mM
iodoacetamide and incubating at room temperature in the dark for 20 min. HPLC
purification of the alkylated callinectin, and a non-alkylated aliquot (25 pmols) of
callinectin, were done on a Hewlett Packard 1090 system equipped with a 1 mm × 25 cm
Vydac C18 (5 micron particle size, 300 Å pore size) reverse phase column equilibrated with
98% Buffer A (0.06% TFA) and 2% Buffer B (0.052% TFA, 80% acetonitrile). Callinectin
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was eluted at 50 μl/min with the following gradient program: 0-60 min (2-37% Buffer B),
60-90 min (37-75% Buffer B) and 90-105 min (75-98% Buffer B), with detection at 210 nm.
Edman chemical degradation was performed on 75% of this alkylated callinectin using an
Applied Biosystems Procise cLC Peptide/Protein sequencer. Thirty two cycles were
sequenced, including 4 carboxamidomethylated cysteines.
Protease treatment was used to determine the C-terminal amino acid, and to identify residue
8. Approximately 125 pmols of callinectin was speedvacuumed dry, dissolved in 25 μl of
10% acetonitrile/10 mM ammonium bicarbonate, and reduced using 5.5 μl of 4.5 mM
dithiothreitol. After incubating at 37°C for 20 min, the sample was alkylated by adding 5.5
μl of 10 mM iodoacetamide, with incubation in the dark at room temperature for 20 min.
After speedvac drying, the sample was dissolved in 35 μl of 1.0 μg/ml trypsin (Promega) in
10% acetonitrile/10 mM ammonium bicarbonate, and incubated at 37°C for 18 hr. MALDI-
MS was performed on one μl of the digest after mixing with matrix as described above.
Additional ESI mass spectrometry was performed on a one pmol aliquot of the tryptic
digest. The sample was first desalted on a C18 ZipTip® (Millipore); the tip (P10 size) was
washed five times with 10 μl of 50% acetonitrile/0.1% TFA, equilibrated five times with 10
μl of 0.1% TFA and then the sample was bound to the tip. Prior to elution of the digest, the
tip was again washed five times with 10 μl of 0.1% TFA (to remove salts) and the sample
was eluted in three μl of 0.1% formic acid/50% acetonitrile/50% water. The eluted sample
was subjected to nanospray MS on a Micromass Q-Tof Ultima mass spectrometer.
Micromass type B nanovials (#M956230AD1) were used to spray the sample into the mass
spectrometer with a voltage of 1.4 kV applied. Masses were chosen manually for MS/MS
fragmentation based on the predicted tryptic masses from the Edman sequencing results and
the MALDI-MS spectra.
A final intact mass of non-alkylated callinectin was acquired using LCMS on a LTQ
Orbitrap mass spectrometer. This instrument was equipped with a Waters nanoACQUITY
UPLC system, and used a Waters Symmetry® C18 180 μm × 20 mm trap column and a 1.7
μm, 75 μm × 250 mm nanoAcquity™ UPLC™ column at 35°C for peptide separation.
Trapping was done at 15 μl/min, 99% Buffer A (100% water, 0.1% formic acid) for one
min. Separation was performed at 300 nl/min with Buffer A (0.1% formic acid in water) and
Buffer B (0.075% formic acid in acetonitrile). A linear gradient (51 min) was run with 5%
Buffer B at initial conditions, 50% Buffer B at 50 min, and 85% Buffer B at 51 min. MS
was acquired in the Orbitrap using one microscan, and a maximum inject time of 900
milliseconds.
2.2 Bioinformatics
Homology searches were performed against the SwissProt, NCBInr, PAT and Month
databases with the Basic Local Alignment Search Tool (BLAST) provided by the NCBI
server (http://www.ncbi.nlm.nih.gov/BLAST). Homology searches of full and partial
sequences were also performed against the Antimicrobial Peptide Database
(http://aps.unmc.edu/AP/main.html) (Wang and Wang, 2004) and against the ANTIMIC
(http://research.i2r.a-star.edu.sg/Templar/DB/ANTIMIC/) and CAMP
(http://www.bicnirrh.res.in/antimicrobial) databases of AMP sequences (Brahmachary et al.,
2004; Thomas et al., 2010). Isoelectric point was predicted using the Skoog and Wichmann
(1986) calculation (in GPMAW Version 8.2, Lighthouse Data).
2.3 Synthesis of Callinectin-Like Peptide (CLP)
While studies were ongoing to identify the complete sequence of native callinectin, we
synthesized a peptide that was based upon the sequence data we had available at the time.
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This callinectin-like peptide (CLP) was eventually found to vary from native callinectin in
having an unmodified tryptophan residue at position 1, a glycine at position 8, and a free C-
terminus. CLP was synthesized via Fmoc chemistry on a Rainin Symphony instrument that
provides on instrument cleavage of the peptide from the resin. After synthesis, CLP was
purified via analytical reverse phase HPLC using a YMC C18 column (4 mm × 50 mm, 3
micron particle size, 120 angstrom pore size support) and an acetonitrile gradient that was
eluted at one ml/min where Buffer A was 0.05% TFA in water and Buffer B was 80%
acetonitrile/0.05% TFA. CLP was detected by its absorbance at 210 nm. Mass spectrometry
of an aliquot of purified CLP was carried out on a Micromass TofSpec SE mass
spectrometer that was operated in positive ion mode and equipped with a nitrogen laser (337
nm), a reflectron, delayed extraction and a post acceleration detector. The purified peptide
was lyophilized from 0.05% TFA/acetonitrile solution and stored dessicated under argon gas
until reconstitution in solvent.
2.4 Anti-CLP Antibody
Two milligrams of CLP was conjugated to keyhole limpet hemocyanin (KLH) using
carbodiimide chemistry, which linked the peptide to KLH via both the N-terminal and the C-
terminal. The conjugation via the terminal amino acid allows tertiary conformation of the
peptide that may be expected to mimic that in the native peptide, thus eliciting anti-
conformational antibodies important for recognizing the native peptide. Immunogen was
mixed with Complete Freund’s Adjuvant (1:1) and KLH-conjugated peptide was injected
into two New Zealand white rabbits at 5 subcutaneous sites (0.2 ml per site, 100 μg/
injection) on days 0, 14, 28 and 42. Thirty ml of antiserum was collected from each rabbit
on days 35 and 45. The antiserum was pooled and was then affinity-purified using CLP
conjugated to cyanogen bromide-activated agarose as an immunosorbent (10.5 mg of CLP
was reacted with 15 g of agarose). One hundred and twenty ml of antiserum (two 30 ml
bleeds from two rabbits) was loaded onto the column (Uniflow 4, Sterogene, Carlsbad, CA).
After washing, the affinity-purified antibody was eluted and concentrated.
This method produces greater than 0.1 mg of peptide-specific antibody per mL of antiserum,
as determined by recovered affinity-purified antibody. Antibody was greater than 95% IgG,
as determined by immunoelectrophoresis using antibodies specific for rabbit IgG, IgM and
serum proteins. The titer of the antibody was determined via ELISA, using CLP as the
antigen coated onto a microtiter plate. Pure CLP (10 μg/mL in PBS, pH 7.2-7.5) was coated
onto a microtiter plate at room temperature for 1 h. The plate was then washed and post-
coated with 1% BSA in PBS for 30 min. The plate was washed and then dilutions of
antibody in 1% BSA/PBS/0.01% Tween 20 were added, beginning at 1 μg antibody/mL.
After incubation for 1 h, the plate was washed, followed by addition of peroxidase-
conjugated goat anti-rabbit IgG (h&l) in 1% BSA/PBS/0.01% Tween 20. After incubation
for 1 h, the plate was washed and peroxidase substrate was added, incubated for 15 min, and
then stopped with 1 N HCl (1:1). The absorbance was then read at 450 nm. The titer was
read as the reciprocal of the antibody dilution (dilution of a 1 mg/mL solution) that produced
a net optical density of 1.0, compared to a blank (diluent-only well), which had an OD < 0.1.
The titer of the antibody used in all assays was approximately 1:159,000. The peptide-
specific antibody would have less than 1% cross-reactivity by ELISA, where 1% cross-
reactivity is 100 times more antibody than would be required to produce the same optical
density with either free KLH or free peptide that shared less than 3 amino acids in the
sequence. Western blotting also showed that this antibody strongly reacted with native
callinectin (data not shown).
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A 0.5 ml sample of blue crab hemolymph was aspirated into 2.5 ml of 10% NBF. The cells
were centrifuged at 2390 × g and then washed twice with 0.1 M Sorensen’s phosphate buffer
(pH 7.2-7.4), and vortexed to re-suspend the cells between washes. The cells were then
embedded in molten 3% agar (Fisher Scientific, Fair Lawn, NJ), cooled until the agar
hardened, and cut into cubes less than 1 mm thick. The agar-embedded cells were
dehydrated in a graded ethanol series culminating in 100% ethanol. They were then placed
into 100% LR White resin (Electron Microscopy Sciences, Fort Washington, PA) overnight
at room temperature. The next day, they were incubated in three changes of fresh LR White
resin (1 hr, 1 hr, and 3 hr). The samples were then placed in capped gelatin capsules with
fresh LR White resin and polymerized overnight at 55°C. Semi-thin sections (0.5 μm) were
cut with a glass knife and stained with toluidine blue O for light microscopic evaluation. The
blocks were then trimmed to include as many cells as possible before ultrathin (90 nm)
sections were cut with a diamond knife. Sections were placed on carbon-formvar-coated
stainless steel grids.
Immunolabeling of grids was accomplished by floating the grids face down on single
droplets of the various reagents on Parafilm pushed into a well of a 24-well tissue culture
plate. All incubations were done at room temperature while gently rocking the 24-well plate
on an Adams nutator (Clay Adams, Parsnippany, NJ) for the duration of the incubation
period. Grids were first washed for 10 min in washing buffer (PBS with 1% BSA and 3%
normal goat serum), followed by incubation for 1 hr in primary antibody (anti-CLP, 1000
μg/ml, titer 1:159,000 diluted with washing buffer to produce 1:50, 1:100, and 1:200
dilutions). A negative control was incubated in washing buffer alone. Grids were then
washed four times (5 min per wash) in washing buffer, followed by incubation for 30 min in
secondary antibody (gold-anti-rabbit Ig, [#G7402, Sigma Chemical, St. Louis, MO] diluted
in washing buffer at a concentration of 1:40). Grids were then washed five times (4 min per
wash) in PBS, followed by a 5 min wash in distilled water. These grids were viewed and
photographed with a Philips EM-208S transmission electron microscope (FEI Company,
Hillsboro, Oregon).
For routine transmission electron microscopy (TEM), another 0.5 ml sample of blue crab
hemolymph was aspirated into 2.5 ml of 4F:1G fixative (McDowell and Trump, 1976). This
sample was agar embedded using the same procedure above. The samples were then place
into 1% osmium tetroxide for one hour. The osmicated cells were dehydrated in an
ascending series of ethanol, ending with 100% ethanol. After the ethanol series, the sample
was rinsed 2 times with 100% acetone for 10 minutes each. It was then infiltrated with 1:1
acetone/Spurr’s epoxy resin (Spurr, 1969) for 30 min, followed by two 1 hr changes of
100% resin. The samples were then placed into flat embedding molds filled with fresh resin.
Semithin sections (0.5 μm) were prepared with a glass knife and stained with toluidine blue
O. The blocks were then trimmed to include as many cells as possible as determined by light
microscopic evaluation of the semithin sections. Ultrathin sections (90 nm) were cut with a
diamond knife, transferred to 200 mesh copper grids, and post-stained with uranyl acetate
and Reynold’s lead citrate. Grids were viewed and photographed with a Philips EM-208S
transmission electron microscope.
3. RESULTS
3.1 Primary Structure of Callinectin
The partial sequence for callinectin that we had previously identified (Khoo et al., 1999) was
for a 26-residue peptide. However, the mass of the protein identified via MALDI-MS in our
current callinectin study was determined to be MH 3647.0 Da (average mass) with 3
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additional masses at +16 Da from this parent mass (suggesting sites of oxidation) with the
most intense mass at MH 3695.16 (Fig. 1). This indicated that either the peptide had a large
posttranslational modification or that the protein was longer than 26 residues. In order to
prepare for an Edman chemical degradation analysis, callinectin was alkylated to modify
cysteines/cystines to carboxamidomethylated cysteine (CAM cys). The latter is a cysteine
modification that is readily identified during Edman sequencing (Hunkapiller, 1988). Both
the alkylated and non-alkylated proteins were HPLC-purified. Edman sequencing of the
alklyated callinectin provided 30 amino acids of sequence, with a missing residue at position
8, four carboxamidomethylated cysteines (residues 20, 22, 27 and 29) and an unknown C-
terminus termination.
MALDI-MS peptide mass fingerprinting as well as nanospray MS/MS and LC-MS/MS
analysis (see Supplementary Tables 1 and 2; Supplementary Figures 1-7) of a tryptic
digestion of callinectin confirmed the Edman sequence and identified the C-terminal
peptide. Nanospray MS/MS spectra of the C-terminal peptide revealed the C-terminus of the
protein to be the tyrosine at residue 32, with C-terminal amidation (Supplementary Fig. 8).
In order to determine residue 8, another intact mass was obtained on a LTQ Orbitrap
XLwith 60,000 resolution. The LC-MS spectra showed a major observed protonated mass
(739.55M+5) of 3693.75 Da (Supplementary Fig. 9). Again, masses corresponding to the
major mass minus a series of 16 Da were observed, indicating that callinectin has multiple
oxidation states. The amino terminal tryptophan (which is the only possible amino acid that
could oxidize in callinectin) must therefore oxidize to hydroxy-N-formylkynurenine (+48
amu), N-formylkynurenine (+32 amu), and hydroxy-tryptophan (+16 amu), with the
hydroxyl-N-formylkyurenine modification as the major mass. Assuming two disulfide
bonds, the predicted monoisotopic mass without residue 8 is 3537.36 Da which is 156.39 Da
different from the Orbitrap protonated mass of 3693.75 Da. The only residue mass that fits
this mass difference is arginine (156 amu). Hence, based on this mass difference, residue 8
was assigned to be arginine. Unfortunately, the predicted tryptic peptide FRVGR was not
observed in either the MALDI-MS digest analysis or the MS/MS analysis (predicted
protonated mass 634.37 Da).
Figure 2 shows the Edman sequence that was determined, along with the mass
spectrometrically-identified peptides (partially proteolysed peptides that were identified are
not shown). A Protein BLAST search of the complete callinectin sequence against the
NCBInr database showed homology to arasins, AMPs recently isolated from the small
spider crab (Hyas araneus) (Stensvåg et al., 2008). Callinectin is highly basic, with a
calculated theoretical PI of 12.8 with disulfide bonds, with a net positive charge of +6.
3.2 Intracellular Localization of Callinectin
Our definition of hemocyte types was primarily based upon the morphological descriptions
of (Clare and Lumb, 1994), who followed the classification scheme of Hose et al. (1990). At
the ultrastructural level, hemocytes were typically spherical or elliptical, and granules, when
present, were either striated, reticulated, or electron dense. There were three hemocyte types
(cell sizes were measured using the longest or widest axis of each cell): hyaline cells, small
granule hemocytes, and large granule hemocytes. Hyaline cells ranged from 4.5-8.0 μm;
they had a central nucleus and a high nucleocytoplasmic ratio. They typically had between
0-10 reticulated and/or striated granules per cell. These cells appeared agranular via light
microscopy, so it would seem that the granules that are apparent correspond to the electron
dense granules found in the small and large granule hemocytes. Small granule hemocytes
(semi-granulocytes) ranged from 6-11 μm. They had a central nucleus and a low
nucleocytoplasmic ratio. They had mostly small (0.5 μm or slightly smaller), electron dense
granules. In one particular cell, larger (0.75 μm) electron dense granules were found. The
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other granule types were rare but present. Large granule hemocytes (granulocytes) also
ranged from 6-11 μm in size. They had an eccentric nucleus and a low nucleocytoplasmic
ratio. They had primarily large electron dense granules (approximately 1.0 μm) that filled
most of the cytoplasm, but an occasional reticulated or striated granule was present (Fig. 3).
Via electron microscopy, hemocytes prominently reacted with anti-CLP antibody.
Immunoreactivity was consistently present in the large, electron-dense granules of the large
granule hemocytes (all 10 large granule hemocytes were positive). Immunostaining of the
granules was variable, with granules having few to many gold particles. None of the 7
hyaline or 6 small granule hemocytes was positive for callinectin. One grid was not treated
with primary antibody and all cells in the section were negative (Fig. 3).
4. DISCUSSION
4.1 Primary Structure of Callinectin
For callinectin, high resolution LC-MS analysis (LTQ Orbitrap) revealed the mass of the
trioxidized tryptophan form (oxidation was based on the series of minus 16 Da masses
called hydroxy-N-formylkynurenine) to be 3693.75 Da and based on this accurate mass,
residue 8 was concluded to be arginine. Edman chemical degradation combined with
MALDI-MS, nanospray MS/MS and intact mass (high resolution) spectra determined the
sequence of callinectin to be WNSNRRFRVGRPPVVGRPGCVCFRAPCPCSNY, where
the C-terminus is amidated. Potential disulfide bridges were not explored but if the three-
dimensional structure of callinectin is similar to other cysteine-rich antimicrobial peptides,
the four cysteines probably form two disulfide bridges (which we have assumed), giving the
peptide a great degree of structural rigidity. Callinectin’s oxidatively decarboxylated
aromatic C-terminal residue may also confer proteolytic resistance, as in halocyamines and
plicatamide, which are AMPs from tunicates (Galinier et al., 2009). This might also at least
partly explain the highly stable nature of this peptide and our ability to reproducibly and
accurately measure antibacterial activity in blue crab serum, even after very long periods of
storage (years) (Noga et al., 1994). This C-terminal amide also increases its net cationic
charge and consequently the electrostatic attraction to targets like negatively charged
bacterial membranes (Shai, 2002).
Callinectin exists as three isomers that vary in the functional group on the tryptophan
residue. The most prevalent isomer had a hydroxy-N-formylkynurenine group, with the
other two modifications (N-formylkynurenine and hydroxytryptophan) being less abundant.
Tryptophan modifications have been documented in AMPs of a number of aquatic animals.
The most common modification is bromination (bromotryptophan). This modification
occurs in styelin D from the tunicate Styela clava (Lehrer et al., 2001), as well as hedistin, a
novel antimicrobial peptide in NK cells of the marine polychaete worm, Nereis diversicolor
(Tasiemski et al., 2007). Other AMPs with bromotryptophan include strongylocin 2 and
centrocins from the green sea urchin (Strongylocentrotus droebachiensis) (Li et al., 2010),
and hagfish cathelicidin isolated from the intestine of Atlantic hagfish (Myxine glutinosa)
(Shinnar et al., 2003). The presence of bromotryptophan is associated with increased
resistance to proteolysis (Shinnar et al., 2003). Hydroxylated tryptophan occurs in MGD-2,
an arthropod defensin from the Mediterranean mussel (Mytilus galloprovincialis) (Yang et
al., 2000) and in piscidin 4, a member of the piscidin family from hybrid striped bass
(Morone saxatilis × M. chrysops) (Noga et al., 2009; Salger et al., 2010).
In some cases, the modified tryptophan is needed for full expression of antimicrobial
activity. Synthesis of MGD-2 without hydroxylation of its tryptophan residue results in
much lower activity against certain Gram-negative bacteria (Yang et al., 2000). However, in
other cases, potent antimicrobial activity is still expressed after deletion of the modified
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amino acid (Shinnar et al., 2003) and does not appear to affect this function (Tasiemski et
al., 2007; Noga et al., 2009). The functional significance of the tryptophan modifications in
callinectin are unknown, but it is possible that they might result in diminished activity.
Tryptophan oxidation is often an indicator of oxidative stress and frequently accompanies
loss of function of a protein (Fedorova et al., 2010). Cobratoxin, a 6.2 kDa peptide that binds
to plasma membrane receptors, is inactivated when its single tryptophan residue is oxidized
to either N’-formylkynurenine or bromotryptophan (Chang and Hayashi, 1969). Oxidation
of the tryptophan in lysozyme abrogates its enzymatic activity (Kuroda et al., 1975). It has
been suggested that the most susceptible tryptophan residues in certain proteins are “hot
spots” for oxidation in close proximity to a source of reactive oxygen species (Taylor et al.,
2003). Thus, it is interesting that the antioxidant enzyme, superoxide dismutase, has been
localized to the plasma membrane of some crustacean granulocytes (Johansson et al., 2000),
which is the cell type in blue crabs that stores callinectin (see below).
Callinectin has significant amino acid sequence similarity to arasins, AMPs recently isolated
from the hemocytes of the small spider crab (Hyas araneus). However, arasin 1, the only
arasin yet purified, has a free C-terminus (Stensvåg et al., 2008) and no modifications on its
tryptophan residue. Callinectin and arasins both have a chimeric structure, with a proline-,
arginine- rich N-terminus (comprising about 16% and 19%, respectively, of callinectin’s
amino acids) and a similar cysteine motif in the C-terminus (Fig. 2). This same cysteine
array is also expressed in other AMPs including mammalian protegrins as well as
tachyplesins, polyphemeusins, androctonin and gomesin from arthropods (Stensvåg et al.,
2008). It is likely that if disulfide bonds are present in callinectin, they are most probably
C22-C27 and C20-C29, which is the type of motif found in the aforementioned AMPs.
4.2 Immunolocalization of Callinectin
Our identification of the three major hemocyte types in blue crabs agreed well with those
previously published by Clare and Lumb (1994), as well as the generally recognized
classification scheme for crustaceans (Matozzo and Marin, 2010). The only cell structures
that we did not observe were stellate forms of electron-dense granules. The appearance of
these granules in Clare and Lumb (1994) is somewhat similar to the “activated” granules of
Pacific white shrimp after exposure to pathogenic bacteria (Muñoz et al., 2002). Thus, our
failure to observe this granule type in our cell preparation might have been because our cell
sample was more quickly preserved. Cell architecture was also well-preserved with use of
the 4F:1G, a relatively low osmolality fixative.
Hemocytes that reacted with anti-CLP antibodies were exclusively large granulocytes. The
cell we have termed an intermediate cell might be between developmental stages of the
small and large granule hemocytes because the granules are in between the sizes of the
granules for the respective cells. Variability in the concentrations of antibodies and
techniques used could account for the variable labeling results between studies.
While a number of AMPs have been identified from solid tissues of a number of animals
(e.g., epithelial defensins), all AMP that have been identified in crustaceans have been
isolated from and/or localized to hemocytes, including penaedins (Muñoz et al., 2002), the
6.5 kDa shore crab peptide (Schnapp et al., 1996) and armadillidin (Herbiniére et al., 2005).
The 11.5 kDa shore crab protein (crustin) as well as black tiger shrimp ALF are also present
in hemocytes (Relf et al., 1999, Somboonwiwat et al., 2005).
Our findings are somewhat similar to those of Muñoz et al (2002), who immunochemically
identified penaeidin in the granules of both small and large granule hemocytes, while
hyaline cells were negative. While some of the small granules in small granule hemocytes
were also significantly positive, they were less so than the large granule hemocytes
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(Destoumieux et al., 2000). Penaeidins are also synthesized in hemocytes (Destoumieux et
al., 2000). Horseshoe crabs (Tachypleus), a chelicerate arthropod, have a single predominant
hemocyte type, the amoebocyte, which has both large and small granules (Iwanaga et al.,
1998).
Localization of callinectin in granulocytes suggests that they would not be directly secreted
into the plasma after synthesis, but rather would be stored as a mature peptide in the
granules. How callinectin is released from the granulocytes is unknown. In horseshoe crabs
(chelicerates), microbial products such as β-glucan or lipopolysaccharide stimulate
granulocytes to degranulate, releasing the AMP tachyplesin and other antimicrobial factors
into the plasma (Iwanaga et al., 1998). However, penaedins appear to be released from the
granules directly into the hemocyte cytoplam after stimulation by bacteria. This then
apparently is followed by cell lysis and the release of the AMPs into the extracellular space
(Muñoz et al., 2002).
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MALDI-MS of callinectin. The intact mass of callinectin was initially determined using
MALDI-MS (Micromass TofSPec SE) in linear mode. The major species was observed at a
singly charged M+H of 3695.16 Da with a series of masses at minus 16 Da, 2 × 16 Da and 3
× 16 Da. This suggested that the major state of callinectin is a trioxidized form. The doubly
charged M+2 ion was also observed at 1848.49 Da, with a doubly charged series of masses at
minus 8 Da.
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Primary structure of callinectin.
a). Amino acid sequence of callinectin. The amino acid sequence of callinectin was
determined using multiple approaches of Edman chemical degradation and tryptic digestion
followed by LC-MS/MS analysis (Micromass Q-Tof Ultima and Thermo Scientific LTQ
Orbitrap XL mass spectrometers) and an accurate intact mass (LTQ Orbitrap). Each residue
was identified using Edman sequencing, except for three residues: the proline at position 28
was verified by MS/MS of a tryptic digest of callinectin; the arginine at position 6 was
confirmed with a tryptic peptide; the arginine at position 8 was determined based on the
accurate intact mass with tryptophan modification. The observed intact M+H mass with the
tryptophan modification (+48 Da, called hydroxy-N-formylkynurenine) is 3693.75 Da. The
calculated intact M+H mass with hydroxy-N-formylkynurenine and 2 disulfide bonds is
3693.73 Da. The last portion of the sequence was determined by LC-MS/MS of the C-
terminal tryptic peptide, which showed that the C-terminus is amidated.
b) Comparison of the amino acid sequences of callinectin, arasin 1 and arasin 2. Residues
are numbered in accordance with the callinectin sequence. Gaps are situated to optimize
similarities. The cysteines are in bold. Shaded amino acids are identical to arasin 1 and/or
arasin 2. The O (°) indicates oxidization, as either hydroxy-N-formylkynurenine, N-
formylkynurenine or hydroxy-tryptophan. The asterisk (*) indicates C-terminal amidation.
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Transmission electron micrographs of blue crab hemocytes. SG = striated granules, EDG =
electron-dense granules, N = nucleus. Bar = 1 μm.
a) Hyaline cell
b) Small granule hemocyte
c) Large granule hemocyte
d) Large granule hemocyte reacted only with gold-labeled goat-anti-rabbit antibody.
e) Large granule hemocyte reacted with rabbit anti-CLP antibody and goat anti-rabbit gold-
labeled antibody. Note gold particles in the EDG.
f) Closer view of Fig. 3e, showing immunopositive granules
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